NASDAQ:BSGM BioSig Technologies Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioSig Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.97 -0.63 (-7.33 %) (As of 09/21/2020 02:19 PM ET) Add Compare Share Today's Range$7.79Now: $7.97▼$8.7150-Day Range$6.82MA: $7.68▼$9.1052-Week Range$2.36Now: $7.97▼$12.43Volume34,378 shsAverage Volume671,695 shsMarket Capitalization$236.29 millionP/E RatioN/ADividend YieldN/ABeta1.33 ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial Media BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is headquartered in Los Angeles, California.Read More Beat the Market (BTM) Rank™ 2.5 Analyst's Opinion Consensus RatingBioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.00, BioSig Technologies has a forecasted upside of 12.9% from its current price of $7.97.Amount of Analyst CoverageBioSig Technologies has received no research coverage in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesBioSig Technologies has received 94 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBioSig Technologies has received 79 “underperform” votes. (Add your “underperform” vote.)Community SentimentBioSig Technologies has received 54.34% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BioSig Technologies and other stocks. Vote “Outperform” if you believe BSGM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BSGM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBioSig Technologies does not currently pay a dividend.Dividend GrowthBioSig Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioSig Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 19.49% of the stock of BioSig Technologies is held by insiders.Percentage Held by InstitutionsOnly 19.66% of the stock of BioSig Technologies is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioBioSig Technologies has a P/B Ratio of 15.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.04 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BSGM Previous Symbol CUSIPN/A CIKN/A Webwww.biosig.com Phone203-409-5444Debt Debt-to-Equity RatioN/A Current Ratio10.72 Quick Ratio10.49Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.53 per share Price / Book15.04Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-34,060,000.00 Net MarginsN/A Return on Equity-269.49% Return on Assets-237.72%Miscellaneous Employees20 Outstanding Shares29,648,000Market Cap$236.29 million Next Earnings Date10/28/2020 (Estimated) OptionableNot Optionable $7.97 -0.63 (-7.33 %) (As of 09/21/2020 02:19 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive BSGM News and Ratings via Email Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions How has BioSig Technologies' stock been impacted by COVID-19? BioSig Technologies' stock was trading at $3.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BSGM stock has increased by 153.8% and is now trading at $7.97. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of BioSig Technologies? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BioSig Technologies. When is BioSig Technologies' next earnings date? BioSig Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020. View our earnings forecast for BioSig Technologies. How were BioSig Technologies' earnings last quarter? BioSig Technologies Inc (NASDAQ:BSGM) released its quarterly earnings results on Thursday, August, 6th. The company reported ($0.72) earnings per share (EPS) for the quarter. View BioSig Technologies' earnings history. What price target have analysts set for BSGM? 1 brokers have issued 1-year target prices for BioSig Technologies' stock. Their forecasts range from $9.00 to $9.00. On average, they expect BioSig Technologies' stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 12.9% from the stock's current price. View analysts' price targets for BioSig Technologies. Who are some of BioSig Technologies' key competitors? Some companies that are related to BioSig Technologies include BioLife Solutions (BLFS), Natus Medical (NTUS), Zynex (ZYXI), AxoGen (AXGN), Viewray (VRAY), TransMedics Group (TMDX), Cutera (CUTR), Semler Scientific (SMLR), Stereotaxis (STXS), Fonar (FONR), Soleno Therapeutics (SLNO), Edap Tms (EDAP), Electromed (ELMD), electroCore (ECOR) and Fc Global Realty (FCRE). View all competitors. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Roku (ROKU), Pfizer (PFE), Vaxart (VXRT), Amarin (AMRN), Micron Technology (MU), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX) and Novavax (NVAX). Who are BioSig Technologies' key executives? BioSig Technologies' management team includes the following people: Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 51)Mr. Steven Chaussy, Chief Financial Officer (Age 65)Ms. Lora Mikolaitis, VP of Admin. (Age 46)Mrs. Tiffini Wittwer, Chief Regulatory & Compliance OfficerMr. John Kowalski, VP of Sales What is BioSig Technologies' stock symbol? BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM." Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Zeke Capital Advisors LLC (0.83%), Anson Funds Management LP (0.63%), Federated Hermes Inc. (0.49%), Cambridge Investment Research Advisors Inc. (0.44%), EAM Investors LLC (0.23%) and Nuveen Asset Management LLC (0.23%). Company insiders that own BioSig Technologies stock include Jerome B Zeldis, Kenneth L Londoner, Martha Pease, Samuel E Navarro and Steve Chaussy. View institutional ownership trends for BioSig Technologies. Which institutional investors are selling BioSig Technologies stock? BSGM stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Zeke Capital Advisors LLC, and UBS Group AG. View insider buying and selling activity for BioSig Technologies. Which institutional investors are buying BioSig Technologies stock? BSGM stock was bought by a variety of institutional investors in the last quarter, including Anson Funds Management LP, Federated Hermes Inc., EAM Investors LLC, California Public Employees Retirement System, Hudson Bay Capital Management LP, American Financial Advisors LLC, Advisor Group Holdings Inc., and Valmark Advisers Inc.. Company insiders that have bought BioSig Technologies stock in the last two years include Jerome B Zeldis, Kenneth L Londoner, Martha Pease, Samuel E Navarro, and Steve Chaussy. View insider buying and selling activity for BioSig Technologies. How do I buy shares of BioSig Technologies? Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BioSig Technologies' stock price today? One share of BSGM stock can currently be purchased for approximately $7.97. How big of a company is BioSig Technologies? BioSig Technologies has a market capitalization of $236.29 million. BioSig Technologies employs 20 workers across the globe. What is BioSig Technologies' official website? The official website for BioSig Technologies is www.biosig.com. How can I contact BioSig Technologies? BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company can be reached via phone at 203-409-5444 or via email at [email protected] This page was last updated on 9/21/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
